This compound is a bis-benzylisoquinoline derivative present as a salt form with oxalic acid. It is primarily supplied as a neuromuscular blocking agent for use in pharmaceutical manufacturing and research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 64228-78-0
Cisatracurium besylate
pharmaceutical raw material
Atracurium
pharmaceutical raw material
Mivacurium chloride
pharmaceutical raw material
Rocuronium bromide
pharmaceutical raw material
Atracurium besylate
pharmaceutical raw material
Erythromycin stearate
pharmaceutical raw material
1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide
pharmaceutical raw material
8-Chloro-6-(2-chlorophenyl)-1-ethenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
pharmaceutical raw material
5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]propanoate;oxalic acid
NGJVDNJEQWIMBU-UHFFFAOYSA-N
COC1=C(C=C(C=C1)CC2C3=CC(=C(C=C3CCN2CCC(=O)OCCCCCOC(=O)CCN4CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)OC)OC)OC.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O